Rongtai health(SH:603579) Shang Hai Zheng Quan Bao·2025-08-28 07:21Group 1 - The core viewpoint of the article is the announcement of the company's half-year report for 2025, detailing the financial status and the use of raised funds from convertible bonds [5][27][59] - The company raised a total of RMB 600 million from the issuance of 6 million convertible bonds, with a net amount of RMB 593.98 million after deducting issuance costs [6][7] - As of June 30, 2025, the remaining balance of the raised funds is RMB 527.30 million, which includes RMB 79.30 million in the special account and RMB 448 million in large time deposits [7][14] Group 2 - The company has used RMB 1.93 million of the raised funds in the first half of 2025, with a total of RMB 4.23 million used in 2021, RMB 1.08 million in 2022, and RMB 4.97 million in 2024 [7][12] - The company has not used any idle raised funds to temporarily supplement working capital or for other purposes during the reporting period [13][18] - The company has established a special account for the management of raised funds, ensuring compliance with regulations and proper usage [9][10] Group 3 - The company plans to hold an investor performance briefing on September 4, 2025, to discuss the half-year results and address investor concerns [29][31] - The company’s board of directors and supervisory board have approved the half-year report and the special report on the use of raised funds [27][59] - The company has triggered the conditional redemption clause for its convertible bonds due to the stock price exceeding 130% of the conversion price for a specified period [41][43]